ImmunityBio (IBRX) Change in Inventory (2024 - 2026)

ImmunityBio (IBRX) has 3 years of Change in Inventory data on file, last reported at $5.0 million in Q1 2026.

• On a quarterly basis, Change in Inventory rose 2798.26% year-over-year to $5.0 million in Q1 2026; TTM through Mar 2026 was $11.1 million, a 31.9% increase from a year earlier, with the FY2025 full-year figure at $6.3 million, down 23.54% from the prior year.
• Change in Inventory for Q1 2026 stood at $5.0 million, down from $7.9 million in the prior quarter.
• Over the last five years, Change in Inventory for IBRX reached as high as $7.9 million in Q4 2025 and fell as low as -$1.8 million in Q2 2025.
• Historically, Change in Inventory has averaged $2.4 million across 3 years, with a median of $991500.0 in 2024.
• Across the five-year window, Change in Inventory sank 199.61% in 2025 and surged 2798.26% in 2026, its largest moves.
• Year by year, Change in Inventory stood at $6.3 million in 2024, then advanced by 25.02% to $7.9 million in 2025, then sank by 36.85% to $5.0 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $5.0 million in Q1 2026, $7.9 million in Q4 2025, and $63000.0 in Q3 2025.